tyrosine has been researched along with Thromboembolism in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (41.67) | 29.6817 |
| 2010's | 7 (58.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adina, Q; Bildirici, U; Celikyurt, U; Dervis, E; Ural, D; Yavuz, S | 1 |
| Brinjikji, W; Cloft, HJ; Kallmes, DF; Morales-Valero, SF; Murad, MH | 1 |
| Bruder, M; El-Fiki, A; Güresir, E; Konczalla, J; Lescher, S; Schuss, P; Seifert, V; Vatter, H | 1 |
| Cha, JK; Choi, JH; Huh, JT; Kang, M; Kim, S | 1 |
| Chang, HW; Han, MH; Kang, HS; Kim, JE; Kwon, BJ; Roh, HG; Yoon, SW | 1 |
| Doraiswamy, VA | 1 |
| Alame, G; Cazenave, JP; Freund, M; Gachet, C; Gaertner, S; Hechler, B; Leguay, C; Petitou, M | 1 |
| Chalouhi, N; Hasan, D; Jabbour, P; Kung, D | 1 |
| Amikam, S; Gruberg, L | 1 |
| Amaro, S; Chamorro, A; Planas, AM; Romanos, E | 1 |
| Burns, G; Meola, S; Mohammad, S; Solen, K; Sukavaneshvar, S | 1 |
| Fallon, AM; Hanson, SR; Marzec, UM; Yoganathan, AP | 1 |
1 review(s) available for tyrosine and Thromboembolism
| Article | Year |
|---|---|
Rescue treatment of thromboembolic complications during endovascular treatment of cerebral aneurysms: a meta-analysis.
Topics: Abciximab; Antibodies, Monoclonal; Endovascular Procedures; Eptifibatide; Fibrinolytic Agents; Humans; Immunoglobulin Fab Fragments; Intracranial Aneurysm; Intraoperative Complications; Male; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thromboembolism; Thrombolytic Therapy; Tirofiban; Tyrosine | 2015 |
1 trial(s) available for tyrosine and Thromboembolism
| Article | Year |
|---|---|
Safety and efficacy of tirofiban in stent-assisted coil embolization of intracranial aneurysms.
Topics: Adult; Aged; Cerebral Hemorrhage; Embolization, Therapeutic; Female; Humans; Infusions, Intravenous; Injections, Intravenous; Intracranial Aneurysm; Male; Middle Aged; Platelet Aggregation Inhibitors; Stents; Thromboembolism; Tirofiban; Tyrosine | 2012 |
10 other study(ies) available for tyrosine and Thromboembolism
| Article | Year |
|---|---|
Early Thrombosuction and Tirofiban Use in Knee and Below-Knee Arterial Thrombosis.
Topics: Aged; Aged, 80 and over; Arteries; Embolism; Female; Hemorrhage; Humans; Knee Joint; Leg; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Retrospective Studies; Thrombectomy; Thromboembolism; Tirofiban; Treatment Outcome; Tyrosine | 2017 |
Ventriculostomy-Related Hemorrhage After Treatment of Acutely Ruptured Aneurysms: The Influence of Anticoagulation and Antiplatelet Treatment.
Topics: Acute Disease; Adult; Aged; Aneurysm, Ruptured; Anticoagulants; Aspirin; Cerebral Hemorrhage; Clopidogrel; Endovascular Procedures; Female; Heparin, Low-Molecular-Weight; Humans; Hydrocephalus; Intracranial Aneurysm; Male; Middle Aged; Platelet Aggregation Inhibitors; Retrospective Studies; Thromboembolism; Ticlopidine; Tirofiban; Tyrosine; Ventriculostomy | 2015 |
Safety and Efficacy of Intravenous Tirofiban as Antiplatelet Premedication for Stent-Assisted Coiling in Acutely Ruptured Intracranial Aneurysms.
Topics: Administration, Intravenous; Aged; Aneurysm, Ruptured; Cerebral Hemorrhage; Embolization, Therapeutic; Female; Humans; Intracranial Aneurysm; Male; Middle Aged; Platelet Aggregation Inhibitors; Premedication; Retrospective Studies; Stents; Thromboembolism; Tirofiban; Tyrosine | 2016 |
Intra-arterial tirofiban infusion for thromboembolism during endovascular treatment of intracranial aneurysms.
Topics: Adult; Aged; Cohort Studies; Embolization, Therapeutic; Female; Humans; Infusions, Intra-Arterial; Intracranial Aneurysm; Male; Middle Aged; Radiography; Retrospective Studies; Thromboembolism; Tirofiban; Treatment Outcome; Tyrosine | 2008 |
Letter by Doraiswamy regarding article, "Intensifying platelet inhibition with tirofiban in poor responders to aspirin, clopidogrel, or both agents undergoing elective coronary intervention: results from the double-blind, prospective, randomized Tailoring
Topics: Anticoagulants; Aspirin; Clopidogrel; Confounding Factors, Epidemiologic; Double-Blind Method; Drug Resistance; Elective Surgical Procedures; Hemorrhage; Heparin; Humans; Myocardial Revascularization; Patient Selection; Platelet Aggregation Inhibitors; Postoperative Complications; Randomized Controlled Trials as Topic; Research Design; Thromboembolism; Ticlopidine; Tirofiban; Tyrosine | 2010 |
The antithrombotic activity of EP224283, a neutralizable dual factor Xa inhibitor/glycoprotein IIbIIIa antagonist, exceeds that of the coadministered parent compounds.
Topics: Animals; Biotin; Disease Models, Animal; Drug Combinations; Factor Xa; Factor Xa Inhibitors; Fibrinolytic Agents; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Oligosaccharides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Rats; Thromboembolism; Tirofiban; Tyrosine | 2011 |
Prolonged systemic delivery of tirofiban in a thrombus-laden saphenous vein graft.
Topics: Aged; Coronary Artery Bypass; Coronary Artery Disease; Fibrinolytic Agents; Graft Occlusion, Vascular; Humans; Infusions, Intravenous; Male; Platelet Glycoprotein GPIIb-IIIa Complex; Radiography; Saphenous Vein; Thromboembolism; Tirofiban; Tyrosine | 2003 |
Uric acid reduces brain damage and improves the benefits of rt-PA in a rat model of thromboembolic stroke.
Topics: Animals; Brain Damage, Chronic; Brain Edema; Humans; Infarction, Middle Cerebral Artery; Male; Neuroprotective Agents; Neutrophil Infiltration; Nitrates; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Stroke; Thromboembolism; Tissue Plasminogen Activator; Tyrosine; Uric Acid | 2007 |
Mitigation of device-associated thrombosis and thromboembolism using combinations of heparin and tirofiban.
Topics: Animals; Anticoagulants; Drug Therapy, Combination; Heparin; In Vitro Techniques; Male; Platelet Aggregation Inhibitors; Sheep; Stents; Thromboembolism; Thrombosis; Tirofiban; Tyrosine | 2006 |
Thrombin formation in vitro in response to shear-induced activation of platelets.
Topics: Antithrombin III; Aspirin; Biomedical Engineering; Blood Platelets; Heart Valve Prosthesis; Hemorheology; Humans; In Vitro Techniques; Peptide Hydrolases; Platelet Activation; Platelet Aggregation Inhibitors; Stress, Mechanical; Thrombin; Thromboembolism; Tirofiban; Tyrosine; von Willebrand Factor | 2007 |